Carregant...
Hemodynamic effects of ambrisentan-tadalafil combination therapy on progressive portopulmonary hypertension
Intravenous epoprostenol is recommended for World Health Organization functional class (WHO-FC) IV patients with pulmonary arterial hypertension (PAH) in the latest guidelines. However, in portopulmonary hypertension (PoPH) patients, advanced liver dysfunction and/or thrombocytopenia often makes the...
Guardat en:
| Publicat a: | World J Hepatol |
|---|---|
| Autors principals: | , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Baishideng Publishing Group Inc
2014
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4243157/ https://ncbi.nlm.nih.gov/pubmed/25429321 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4254/wjh.v6.i11.825 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|